Menu
Annual · values202520242023202220212020
Operating Cash Flow-27.95 M USD-38.77 M USD-41.81 M USD-72.34 M USD-47.18 M USD-21.52 M USD
Depreciation & Amortization1.09 M USD1.01 M USD1.05 M USD1.01 M USD726000 USD289000 USD
Stock-Based Compensation2.80 M USD4.36 M USD4.74 M USD10.65 M USD6.90 M USD1.12 M USD
Capital Expenditures1.19 M USD383000 USD804000 USD585000 USD2.71 M USD1.57 M USD
Cash Flow from Investing-1.19 M USD-383000 USD-804000 USD-585000 USD-2.71 M USD-1.57 M USD
Cash Flow from Financing27.50 M USD1.02 M USD174000 USD7000 USD176.77 M USD60.94 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-29.13 M USD-39.15 M USD-42.61 M USD-72.92 M USD-49.89 M USD-23.09 M USD

Hyperfine Inc., a pioneering medical technology firm, develops portable, low-cost magnetic resonance imaging (MRI) systems known for their accessibility and transformative potential in healthcare. Hyperfine's flagship product, the Swoop Portable MRI, is designed to significantly enhance patient care by enabling real-time, bedside imaging, thus extending MRI capabilities beyond traditional clinical settings. This innovation is particularly impactful in emergency rooms, intensive care units, and remote locations where access to conventional MRI facilities may be limited or non-existent. By bridging the gap between advanced imaging and practical application, Hyperfine Inc. plays a crucial role in democratizing healthcare access, speeding up diagnosis, and ultimately improving clinical outcomes. The company’s focus on innovation and accessibility positions it as a key player in the med-tech industry, potentially influencing hospital operations, patient management protocols, and healthcare delivery frameworks worldwide.